Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells
Authors:
- Neena PhilipsNPNeena Philips
- Karyn McFaddenKMKaryn McFadden
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 206 (1) , 63-68
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP‐2 and MMP‐9) by human epithelial breast cancer cellsInternational Journal of Cancer, 2003
- Unique Protein Determinants of the Subtype-selective Ligand Responses of the Estrogen Receptors (ERα and ERβ) at AP-1 SitesJournal of Biological Chemistry, 2001
- Prolactin (PRL)-PRL Receptor System Increases Cell Proliferation Involving JNK (c-Jun Amino Terminal Kinase) and AP-1 Activation: Inhibition by GlucocorticoidsMolecular Endocrinology, 2000
- Hormonal carcinogenesisCarcinogenesis, 2000
- Effects of TGF‐β1 on Prolactin Synthesis and Secretion: an In‐Vitro StudyJournal of Neuroendocrinology, 1999
- Coexpression and Cross-Regulation of the Prolactin Receptor and Sex Steroid Hormone Receptors in Breast CancerThe Journal of Clinical Endocrinology & Metabolism, 1997
- TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expressionBreast Cancer Research and Treatment, 1997
- Cell-specific Induction of Distinct Oncogenes of the Jun Family Is Responsible for Differential Regulation of Collagenase Gene Expression by Transforming Growth Factor-β in Fibroblasts and KeratinocytesJournal of Biological Chemistry, 1996
- INHERITED BREAST CANCERSurgical Clinics of North America, 1996
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987